Medis Product Portfolio

Filters

Therapeutic Area

Toggle

Dosage Form

Toggle

All Results

No results found

Please change the filter settings to find the product(s) you are looking for. You can also use the search function to look up a product.

Clear Filters

Busulfan

Status:
Available
Therapeutic Area:
Antineoplastic and Immunomodulating Agents
Dosage:
6mg/ml
Dosage Form:
Concentrate for Solution for Infusion
Availability:
Available

Cabazitaxel

Status:
Available
Therapeutic Area:
Antineoplastic and Immunomodulating Agents
Dosage:
10mg/ml
Dosage Form:
Concentrate for Solution for Infusion
Availability:
Available

Carboplatin

Status:
Under development
Therapeutic Area:
Antineoplastic and Immunomodulating Agents
Dosage:
10mg/ml (50mg/5ml, 150mg/15ml, 450mg/45ml, 600mg/60ml)
Dosage Form:
Concentrate for Solution for Infusion
Availability:
Under development

Cisplatin

Status:
Available
Therapeutic Area:
Antineoplastic and Immunomodulating Agents
Dosage:
1mg/ml (10mg/10ml, 50mg/50ml, 100mg/100ml)
Dosage Form:
Concentrate for Solution for Infusion
Availability:
Available

Clofarabine

Status:
Available
Therapeutic Area:
Antineoplastic and Immunomodulating Agents
Dosage:
1mg/ml (20mg/20ml)
Dosage Form:
Concentrate for Solution for Infusion
Availability:
Available

Docetaxel - one vial

Status:
Available
Therapeutic Area:
Antineoplastic and Immunomodulating Agents
Dosage:
20mg/ml (20mg/ml, 80mg/4ml, 140mg/7ml, 160mg/8ml)
Dosage Form:
Concentrate for Solution for Infusion
Availability:
Available

Fludarabine

Status:
Available
Therapeutic Area:
Antineoplastic and Immunomodulating Agents
Dosage:
25mg/ml (50mg/2ml)
Dosage Form:
Concentrate for Solution for Infusion
Availability:
Available

Gemcitabine

Status:
Under development
Therapeutic Area:
Antineoplastic and Immunomodulating Agents
Dosage:
40mg/ml (200mg/5ml, 1000mg/25ml, 2000mg/50ml)
Dosage Form:
Concentrate for Solution for Infusion
Availability:
Under development

Irinotecan

Status:
Available
Therapeutic Area:
Antineoplastic and Immunomodulating Agents
Dosage:
20mg/ml (40mg/2ml, 100mg/5ml, 300mg/15ml, 500mg/25ml)
Dosage Form:
Concentrate for Solution for Infusion
Availability:
Available

Paclitaxel

Status:
Available
Therapeutic Area:
Antineoplastic and Immunomodulating Agents
Dosage:
6mg/ml (30mg/5ml, 100mg/16.7ml, 150mg/25ml, 260mg/43.33ml, 300mg/50ml)
Dosage Form:
Concentrate for Solution for Infusion
Availability:
Available

IP Disclaimer: Not all the products are available for all territories. Please check availability with Medis business development.